P

Peijia Medical Ltd
HKEX:9996

Watchlist Manager
Peijia Medical Ltd
HKEX:9996
Watchlist
Price: 3.88 HKD 0.52% Market Closed
Market Cap: 2.5B HKD
Have any thoughts about
Peijia Medical Ltd?
Write Note

Peijia Medical Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Peijia Medical Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
P
Peijia Medical Ltd
HKEX:9996
Income from Continuing Operations
-ÂĄ392.6m
CAGR 3-Years
43%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Income from Continuing Operations
ÂĄ522.1m
CAGR 3-Years
71%
CAGR 5-Years
99%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Income from Continuing Operations
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income from Continuing Operations
ÂĄ12.7B
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Income from Continuing Operations
ÂĄ701.3m
CAGR 3-Years
-13%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Income from Continuing Operations
ÂĄ2B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Peijia Medical Ltd
Glance View

Market Cap
2.6B HKD
Industry
Health Care

Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.

Intrinsic Value
5.28 HKD
Undervaluation 27%
Intrinsic Value
Price
P

See Also

What is Peijia Medical Ltd's Income from Continuing Operations?
Income from Continuing Operations
-392.6m CNY

Based on the financial report for Dec 31, 2023, Peijia Medical Ltd's Income from Continuing Operations amounts to -392.6m CNY.

What is Peijia Medical Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-36%

Over the last year, the Income from Continuing Operations growth was 4%. The average annual Income from Continuing Operations growth rates for Peijia Medical Ltd have been 43% over the past three years , -36% over the past five years .

Back to Top